Advertisement
U.S. Markets closed

BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)

Helsinki - Helsinki Real Time Price. Currency in EUR
0.2900+0.0030 (+1.05%)
At close: 04:57PM EET
Full screen
Previous Close0.2870
Open0.2900
Bid0.2840 x N/A
Ask0.2900 x N/A
Day's Range0.2810 - 0.2900
52 Week Range0.2700 - 0.6640
Volume16,092
Avg. Volume38,177
Market Cap7.469M
Beta (5Y Monthly)-0.51
PE Ratio (TTM)N/A
EPS (TTM)-0.1500
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.40
  • GlobeNewswire

    Changes in BBS-Bioactive Bone Substitutes Plc’s Management Team

    BBS-Bioactive Bone Substitutes Plc, Company announcement, 6 March 2024 at 11:15 a.m. Changes in the BBS-Bioactive Bone Substitutes Plc’s Management Team Oy Jamerco Ltd. has terminated its service contract with BBS-Bioactive Bone Substitutes Ltd (“BBS”). As a result, Jari Kortesluoma’s position as the CFO and member of the management team will end. Kortesluoma will fulfill the responsibilities of CFO throughout the two-month notice period. BBS is currently in the process of searching for a new in

  • GlobeNewswire

    BBS-Bioactive Bone Substitutes Plc: Financial Statements Bulletin 2023: Preparations for commercial phase initiated (unaudited)

    BBS-Bioactive Bone Substitutes Plc, Financial Statements Bulletin 2023, 26 February 2024 at 5.45 p.m. (EET) This is a summary of BBS-Bioactive Bone Substitutes Plc’s Financial Statements Bulletin for January–December 2023. The entire report is attached to this Company Announcement as a pdf file. The report is also available on BBS-Bioactive Bone Substitutes Plc’s website at https://www.bbs-artebone.fi/. Preparations for commercial phase initiated JULY-DECEMBER HIGHLIGHTS In the second half of 20